All for Joomla
All for Webmasters
Hemostasis
Acute Care Diagnostics
Autoimmunity
Transfusion
Transplant
#GiveToGain
WTDay
Cyber Health
EEMEA Learning Center - anti
Increased platelet inhibition after switching from prasugrel to low-dose ticagrelor in Japanese patients with prior myocardial infarction
Read more...
Clinical significance of high on-treatment platelet reactivity in patients with prolonged clopidogrel therapy
Read more...
Influence of Valve Type and Antiplatelet Regimen on Platelet Reactivity After TAVI: Subanalysis of the REAC-TAVI Trial
Read more...
The Effect of Low-Dose Ticagrelor on Platelet Function Profiles in Patients With Stable Coronary Artery Disease in Trinidad: The TWIST Pilot Study
Read more...
Platelet Inhibition with Ticagrelor versus Clopidogrel in Diabetic Patients after Percutaneous Coronary Intervention for Chronic Coronary Syndromes
Read more...
The effect of antiplatelet drug on coronary endothelial and microvascular function: comparison with ticagrelor and clopidogrel
Read more...
Novel use of cangrelor in pediatrics: A pilot cohort study demonstrating use in ventricular assist devices
Read more...
Residual platelet reactivity in low-dose aspirin-treated patients with class 1 obesity
Read more...
Effects of switching from clopidogrel to prasugrel at the chronic phase after coronary stenting on antiplatelet action and vascular endothelial function: Switch-Pras study
Read more...
Pharmacokinetic, pharmacodynamic, and pharmacogenetic assays to monitor clopidogrel therapy
Read more...
2012 update to the Society of Thoracic Surgeons guideline on use of antiplatelet drugs in patients having cardiac and noncardiac operations
Read more...
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the Euro
Read more...
2017 EACTS/EACTA Guidelines on patient blood management for adult cardiac surgery
Read more...
Updated Expert Consensus Statement on Platelet Function and Genetic Testing for Guiding P2Y 12 Receptor Inhibitor Treatment in Percutaneous Coronary Intervention
Read more...
High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients
Read more...
Venous thromboembolism in critically Ill patients with COVID-19: Results of a screening study for deep vein thrombosis
Read more...
Early coagulation tests predict risk stratification and prognosis of COVID-19
Read more...
COVID-19 Related Coagulopathy: A Distinct Entity?
Read more...
The challenges of diagnosing heparin-induced thrombocytopenia in patients with COVID-19
Read more...
Fibrinolysis and COVID‐19: A plasmin paradox
Read more...
Viral infections and their relationship with catastrophic antiphospholipid syndrome: a possible pathogenic mechanism of severe COVID-19 thrombotic complications
Read more...
Anticoagulant and antiarrhythmic effects of heparin in the treatment of COVID-19 patients
Read more...
Heparin - An old drug with multiple potential targets in Covid-19 therapy
Read more...
Hypofibrinolytic state and high thrombin generation may play a major role in SARS-COV2 associated thrombosis
Read more...
Dynamic relationship between D-dimer and COVID-19 severity
Read more...
Hypercoagulability of COVID-19 patients in intensive care unit: A report of thromboelastography findings and other parameters of hemostasis
Read more...
Chronic therapeutic anticoagulation is associated with decreased thrombotic complications in SARS-CoV-2 infection
Read more...
Heparin induced thrombocytopenia antibodies in Covid‐19
Read more...
Incidence of thrombosis and hemorrhage in hospitalized cancer patients with COVID‐19
Read more...
Curative anticoagulation prevents endothelial lesion in COVID-19 patients
Read more...
Fibrinolysis and COVID-19: A tale of two sites?
Read more...
Coagulopathy and Thrombosis as a Result of Severe COVID-19 Infection: A Microvascular Focus
Read more...
Coagulopathy in COVID-19
Read more...
High frequency of antiphospholipid antibodies in critically ill COVID-19 patients: a link with hypercoagulability?
Read more...
The unique characteristics of COVID-19 coagulopathy
Read more...
The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome
Read more...
Coagulation biomarkers are independent predictors of increased oxygen requirements in COVID-19
Read more...
Prevalence of Venous Thromboembolism in Critically Ill COVID-19 Patients: Systematic Review and Meta-Analysis
Read more...
Heparin-induced thrombocytopenia with thrombosis in COVID-19 adult respiratory distress syndrome
Read more...
Frequency of lupus anticoagulant in COVID-19 patients
Read more...
Thromboprophylaxis in a patient with COVID-19 and severe hemophilia A on emicizumab prophylaxis
Read more...
Lupus anticoagulant is frequent in patients with Covid-19
Read more...
Clinical Characteristics of Coronavirus Disease 2019 in China
Read more...
Essential Role of Patient Blood Management in a Pandemic: A Call for Action
Read more...
Current Perspectives of Anticoagulation in Patients With COVID-19
Read more...
COVID-19 Related Arterial Coagulopathy
Read more...
Scientific and Standardization Committee communication: Clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID-19
Read more...
Antiphospholipid antibodies in patients with COVID‐19: A relevant observation?
Read more...
Marked factor V activity elevation in severe COVID‐19 is associated with venous thromboembolism
Read more...
Coronavirus Disease 2019 (COVID-19) Infection Associated With Antiphospholipid Antibodies and Four-Extremity Deep Vein thrombosis in a Previously Healthy Female
Read more...
The vascular side of COVID-19 disease. Position paper of the International Union of Angiology
Read more...
https://pubmed.ncbi.nlm.nih.gov/32339221/
Read more...
Coagulopathy of COVID-19 and antiphospholipid antibodies
Read more...
A proposal for staging COVID-19 coagulopathy
Read more...
COVID-19-associated coagulopathy: An exploration of mechanisms
Read more...
Emergence of institutional antithrombotic protocols for coronavirus 2019
Read more...
COVID-19: a probable role of the anticoagulant Protein S in managing COVID-19-associated coagulopathy
Read more...
Entangling COVID-19 associated thrombosis into a secondary antiphospholipid antibody syndrome: Diagnostic and therapeutic perspectives (Review)
Read more...
D-dimer and mortality in COVID-19: a self-fulfilling prophecy or a pathophysiological clue?
Read more...
Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research
Read more...
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review
Read more...
Impact of anticoagulation prior to COVID-19 infection: a propensity score-matched cohort study
Read more...
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
Read more...
COVID-19 and acute coagulopathy in pregnancy
Read more...
An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study
Read more...
Autoantibodies related to systemic autoimmune rheumatic diseases in severely ill patients with COVID-19
Read more...
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China
Read more...
Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study
Read more...
SARS-CoV-2 and Stroke in a New York Healthcare System
Read more...
Prevalence, specificity, and clinical association of anti-phospholipid antibodies in COVID-19 patients: are the antibodies really guilty?
Read more...
High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study
Read more...
Response to "All these D-dimers in COVID-19"
Read more...
Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2
Read more...
Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology
Read more...
Thromboembolism and anticoagulant therapy during the COVID-19 pandemic: interim clinical guidance from the anticoagulation forum
Read more...
Heparin resistance in COVID-19 patients in the intensive care unit
Read more...
Fibrinolytic therapy for refractory COVID‐19 acute respiratory distress syndrome: Scientific rationale and review
Read more...
Direct oral anticoagulant plasma levels' striking increase in severe COVID-19 respiratory syndrome patients treated with antiviral agents: The Cremona experience
Read more...
In vitro hypercoagulability and ongoing in vivo activation of coagulation and fibrinolysis in COVID-19 patients on anticoagulation
Read more...
Evaluation of COVID-19 coagulopathy; laboratory characterization using thrombin generation and nonconventional haemostasis assays
Read more...
Evaluation of variation in D-dimer levels among COVID-19 and bacterial pneumonia: a retrospective analysis
Read more...
Profile of natural anticoagulant, coagulant factor and anti-phospholipid antibody in critically ill COVID-19 patients
Read more...
COVID-19 hypothesis: Activated protein C for therapy of virus-induced pathologic thromboinflammation
Read more...
Association of Treatment Dose Anticoagulation With In-Hospital Survival Among Hospitalized Patients With COVID-19
Read more...
Clinically significant anticardiolipin antibodies associated with COVID-19
Read more...
Consumptive Coagulopathy and Thrombosis during Severe COVID-19 Infection: Potential Involvement of VWF/ADAMTS13
Read more...
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy
Read more...
Inhaled and systemic heparin as a repurposed direct antiviral drug for prevention and treatment of COVID-19
Read more...
Prominent changes in blood coagulation of patients with SARS-CoV-2 infection
Read more...
Clinical management of severe acute respiratory infection when COVID-19 is suspected (v1.2)
Read more...
First-line therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogeneic blood transfusion in cardiovascular surgery: a retrospective, single-center cohort study
Read more...
Protamine overdose and its impact on coagulation, bleeding, and transfusions after cardiopulmonary bypass: results of a randomized double-blind controlled pilot study
Read more...
Prolonged Activated Clotting Time after Protamine Administration Does Not Indicate Residual Heparinization after Cardiopulmonary Bypass in Pediatric Open Heart Surgery
Read more...
Effect of high or low protamine dosing on postoperative bleeding following heparin anticoagulation in cardiac surgery. A randomised clinical trial
Read more...
Rotational Thromboelastometry Rapidly Predicts Thrombocytopenia and Hypofibrinogenemia During Neonatal Cardiopulmonary Bypass
Read more...
Interval changes in ROTEM values during cardiopulmonary bypass in pediatric cardiac surgery patients
Read more...
Editor's Choice - A Rotational Thromboelastometry Driven Transfusion Strategy Reduces Allogenic Blood Transfusion During Open Thoraco-abdominal Aortic Aneurysm Repair: A Propensity Score Matched Study
Read more...
Interaction of heparin and protamine in presence of overdosage: in vitro study
Read more...
The coagulopathy of cirrhosis assessed by thromboelastometry and its correlation with conventional coagulation parameters
Read more...
Start
Prev
1
2
3
4
Next
End
Page 2 of 4
Werfen.com.
All rights Reserved.
Privacy Policy
|
Cookies Policy
|
Terms of Service
No Internet Connection